BACKGROUND: Prospective cohort studies contribute importantly to understanding the role of lifestyle, genetic, and other factors in chronic disease etiology. METHODS: The American Cancer Society (ACS) recruited a new prospective cohort study, Cancer Prevention Study 3 (CPS-3), between 2006 and 2013 from 35 states and Puerto Rico. Enrollment took place primarily at ACS community events and at community enrollment "drives." At enrollment sites, participants completed a brief survey that included an informed consent, identifying information necessary for follow-up, and key exposure information. They also provided a waist measure and a nonfasting blood sample. Most participants also completed a more comprehensive baseline survey at home that included extensive medical, lifestyle, and other information. Participants will be followed for incident cancers through linkage with state cancer registries and for cause-specific mortality through linkage with the National Death Index. RESULTS: In total, 303,682 participants were enrolled. Of these, 254,650 completed the baseline survey and are considered "fully" enrolled; they will be sent repeat surveys periodically for at least the next 20 years to update exposure information. The remaining participants (n = 49,032) will not be asked to update exposure information but will be followed for outcomes. Twenty-three percent of participants were men, 17.3% reported a race or ethnicity other than "white," and the median age at enrollment was 47 years. CONCLUSIONS: CPS-3 will be a valuable resource for studies of cancer and other outcomes because of its size; its diversity with respect to age, ethnicity, and geography; and the availability of blood samples and detailed questionnaire information collected over time. Cancer 2017;123:2014-2024.
BACKGROUND: Prospective cohort studies contribute importantly to understanding the role of lifestyle, genetic, and other factors in chronic disease etiology. METHODS: The American Cancer Society (ACS) recruited a new prospective cohort study, Cancer Prevention Study 3 (CPS-3), between 2006 and 2013 from 35 states and Puerto Rico. Enrollment took place primarily at ACS community events and at community enrollment "drives." At enrollment sites, participants completed a brief survey that included an informed consent, identifying information necessary for follow-up, and key exposure information. They also provided a waist measure and a nonfasting blood sample. Most participants also completed a more comprehensive baseline survey at home that included extensive medical, lifestyle, and other information. Participants will be followed for incident cancers through linkage with state cancer registries and for cause-specific mortality through linkage with the National Death Index. RESULTS: In total, 303,682 participants were enrolled. Of these, 254,650 completed the baseline survey and are considered "fully" enrolled; they will be sent repeat surveys periodically for at least the next 20 years to update exposure information. The remaining participants (n = 49,032) will not be asked to update exposure information but will be followed for outcomes. Twenty-three percent of participants were men, 17.3% reported a race or ethnicity other than "white," and the median age at enrollment was 47 years. CONCLUSIONS:CPS-3 will be a valuable resource for studies of cancer and other outcomes because of its size; its diversity with respect to age, ethnicity, and geography; and the availability of blood samples and detailed questionnaire information collected over time. Cancer 2017;123:2014-2024.
Authors: Sarah Kozey Keadle; Eli S Kravitz; Charles E Matthews; Marilyn Tseng; Raymond J Carroll Journal: Med Sci Sports Exerc Date: 2019-08 Impact factor: 5.411
Authors: Erika Rees-Punia; Charles E Matthews; Ellen M Evans; Sarah K Keadle; Rebecca L Anderson; Jennifer L Gay; Michael D Schmidt; Susan M Gapstur; Alpa V Patel Journal: Med Sci Sports Exerc Date: 2019-01 Impact factor: 5.411
Authors: Kathryn P Lowry; H Amarens Geuzinge; Natasha K Stout; Oguzhan Alagoz; John Hampton; Karla Kerlikowske; Harry J de Koning; Diana L Miglioretti; Nicolien T van Ravesteyn; Clyde Schechter; Brian L Sprague; Anna N A Tosteson; Amy Trentham-Dietz; Donald Weaver; Martin J Yaffe; Jennifer M Yeh; Fergus J Couch; Chunling Hu; Peter Kraft; Eric C Polley; Jeanne S Mandelblatt; Allison W Kurian; Mark E Robson Journal: JAMA Oncol Date: 2022-04-01 Impact factor: 33.006
Authors: Julie R Palmer; Eric C Polley; Chunling Hu; Esther M John; Christopher Haiman; Steven N Hart; Mia Gaudet; Tuya Pal; Hoda Anton-Culver; Amy Trentham-Dietz; Leslie Bernstein; Christine B Ambrosone; Elisa V Bandera; Kimberly A Bertrand; Traci N Bethea; Chi Gao; Rohan D Gnanaolivu; Hongyan Huang; Kun Y Lee; Loic LeMarchand; Jie Na; Dale P Sandler; Payal D Shah; Siddhartha Yadav; William Yang; Jeffrey N Weitzel; Susan M Domchek; David E Goldgar; Katherine L Nathanson; Peter Kraft; Song Yao; Fergus J Couch Journal: J Natl Cancer Inst Date: 2020-12-14 Impact factor: 13.506
Authors: Amanda E Paluch; Shivangi Bajpai; David R Bassett; Mercedes R Carnethon; Ulf Ekelund; Kelly R Evenson; Deborah A Galuska; Barbara J Jefferis; William E Kraus; I-Min Lee; Charles E Matthews; John D Omura; Alpa V Patel; Carl F Pieper; Erika Rees-Punia; Dhayana Dallmeier; Jochen Klenk; Peter H Whincup; Erin E Dooley; Kelley Pettee Gabriel; Priya Palta; Lisa A Pompeii; Ariel Chernofsky; Martin G Larson; Ramachandran S Vasan; Nicole Spartano; Marcel Ballin; Peter Nordström; Anna Nordström; Sigmund A Anderssen; Bjørge H Hansen; Jennifer A Cochrane; Terence Dwyer; Jing Wang; Luigi Ferrucci; Fangyu Liu; Jennifer Schrack; Jacek Urbanek; Pedro F Saint-Maurice; Naofumi Yamamoto; Yutaka Yoshitake; Robert L Newton; Shengping Yang; Eric J Shiroma; Janet E Fulton Journal: Lancet Public Health Date: 2022-03
Authors: Charles E Matthews; Richard P Troiano; Elizabeth A Salerno; David Berrigan; Shreya B Patel; Eric J Shiroma; Pedro F Saint-Maurice Journal: Med Sci Sports Exerc Date: 2020-12
Authors: Chi Gao; Eric C Polley; Steven N Hart; Hongyan Huang; Chunling Hu; Rohan Gnanaolivu; Jenna Lilyquist; Nicholas J Boddicker; Jie Na; Christine B Ambrosone; Paul L Auer; Leslie Bernstein; Elizabeth S Burnside; A Heather Eliassen; Mia M Gaudet; Christopher Haiman; David J Hunter; Eric J Jacobs; Esther M John; Sara Lindström; Huiyan Ma; Susan L Neuhausen; Polly A Newcomb; Katie M O'Brien; Janet E Olson; Irene M Ong; Alpa V Patel; Julie R Palmer; Dale P Sandler; Rulla Tamimi; Jack A Taylor; Lauren R Teras; Amy Trentham-Dietz; Celine M Vachon; Clarice R Weinberg; Song Yao; Jeffrey N Weitzel; David E Goldgar; Susan M Domchek; Katherine L Nathanson; Fergus J Couch; Peter Kraft Journal: J Clin Oncol Date: 2021-06-08 Impact factor: 50.717
Authors: Andrew T Chan; David A Drew; Long H Nguyen; Amit D Joshi; Wenjie Ma; Chuan-Guo Guo; Chun-Han Lo; Raaj S Mehta; Sohee Kwon; Daniel R Sikavi; Marina V Magicheva-Gupta; Zahra S Fatehi; Jacqueline J Flynn; Brianna M Leonardo; Christine M Albert; Gabriella Andreotti; Laura E Beane-Freeman; Bijal A Balasubramanian; John S Brownstein; Fiona Bruinsma; Annie N Cowan; Anusila Deka; Michael E Ernst; Jane C Figueiredo; Paul W Franks; Christopher D Gardner; Irene M Ghobrial; Christopher A Haiman; Janet E Hall; Sandra L Deming-Halverson; Brenda Kirpach; James V Lacey; Loïc Le Marchand; Catherine R Marinac; Maria Elena Martinez; Roger L Milne; Anne M Murray; Denis Nash; Julie R Palmer; Alpa V Patel; Lynn Rosenberg; Dale P Sandler; Shreela V Sharma; Shepherd H Schurman; Lynne R Wilkens; Jorge E Chavarro; A Heather Eliassen; Jaime E Hart; Jae Hee Kang; Karestan C Koenen; Laura D Kubzansky; Lorelei A Mucci; Sebastien Ourselin; Janet W Rich-Edwards; Mingyang Song; Meir J Stampfer; Claire J Steves; Walter C Willett; Jonathan Wolf; Tim Spector Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-05 Impact factor: 4.090